share_log

白云山(600332.SH):他达拉非片收到药品注册证书

Baiyunshan (600332.SH): Tadalafil tablets have received pharmaceutical registration certificate.

Gelonghui Finance ·  Jun 26 05:44

On June 26th, Gelunhui reported that Guangzhou Baiyunshan Pharmaceutical Co., Ltd., a subsidiary of Baiyunshan (600332.SH), received the Drug Registration Certificate issued by the National Medical Products Administration for Tadalafil Tablets (20mg) from Baiyunshan Pharmaceutical Factory. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor mainly used for the treatment of male erectile dysfunction (ED).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment